Despite the importance of gastrointestinal diseases and their global distribution, affecting millions of individuals around the world, the role and antimicrobial susceptibility patterns of anaerobic bacteria such as those in the Bacteroides fragilis group (BFG) are still unclear in young children. This study investigated the occurrence and distribution of species in the BFG and enterotoxigenic strains in the fecal microbiota of children and their antimicrobial susceptibility patterns. Diarrheic (n=110) and non-diarrheic (n=65) fecal samples from children aged 0-5 years old were evaluated. BFG strains were isolated and identified by conventional biochemical, physiological and molecular approaches. Alternatively, bacteria and enterotoxigenic strains were detected directly from feces by molecular biology. Antimicrobial drug susceptibility patterns were determined by the agar dilution method according to the guidelines for isolated bacteria. BFG was detected in 64.3% of the fecal samples (55% diarrheic and 80.4% non-diarrheic), and 4.6% were enterotoxigenic. Antimicrobial resistance was observed against ampicillin, ampicillin/sulbactam, piperacillin/tazobactam, meropenem, ceftriaxone, clindamycin and chloramphenicol.
INTRODUCTION
The importance of anaerobic bacteria in the etiology of human gastrointestinal infections is well known (30, 39) .
Among these microorganisms, the ten related species of Gramnegative rods of the Bacteroides fragilis group (BFG) stand out. Though taxonomic alterations have been proposed, the group designation Bacteroides fragilis is still used (39) . In spite of the protective function of these resident microorganisms, they can be associated with diseases in the gastrointestinal tract, mainly in situations of acute diarrhea and inflammatory intestinal diseases, among others (30) .
In developing countries, these diseases are some of the most important causes of morbity and especially mortality, in children of low age (13) . However, many cases of diarrhea are not diagnosed, due to mild and self-limited manifestations for which the patients do not seek medical service, or because there is an overload on the public health services, which makes the use of the available medical and laboratory resources difficult (21) . Furthermore, there is a lack of scientific data on the incidence and the epidemiology of these diseases, which may interfere with public health policies, especially in developing countries.
Anaerobic bacteriology demands special routines with regards the collection, transport and processing of biological materials for studies involving the isolation and identification of these microorganisms (27) . In this sense, the correct handling of the clinical specimens is essential for diagnosis and epidemiological research (15) . The search for new methods of study may provide more exact knowledge of the participation of these microorganisms in different ecosystems (6) .
Strains of B. fragilis eliciting intestinal secretions are named enterotoxigenic B. fragilis (ETBF) and their involvement as etiological agents of gastrointestinal diseases
has been highlighted by several scientists in recent years (28, 34) . Epidemiological data suggest that ETBF strains are globally distributed enteric pathogens that cause gastrointestinal disorders in humans, mainly young children. In addition, other animals like calves, lambs, foals, and piglets are susceptible to ETBF-associated diarrheal illnesses. Similar to the case for other enteric pathogens, asymptomatic ETBF colonization is common (34) . This enterotoxin is associated with fluid secretion, exfoliation and alteration of the cytoskeleton of intestinal cells (22) and with the clinical demonstration of colorectal cancer (38) .
In the last 20 years, geographical variations and an increase in resistance to antimicrobial drugs have been reported as a global problem. Periodic monitoring in these organisms of the patterns of susceptibility to drugs has been recommended to enable the appropriate choice of antibiotic therapy to be made (17, 24, 36) .
Regional studies about the incidence and characterization of Bacteroides spp., either enterotoxigenic or not, and their drug susceptibility patterns might provide knowledge of the distribution and the involvement of these bacteria in the diseases related to the gastrointestinal tract in different regions. 
MATERIAL AND METHODS

Specimen collection and microbiological culture
One hundred and seventy five fecal samples were obtained 
Molecular identification of the isolated strains and bacterial detection in feces
Genomic DNA from the isolated bacterial strains and the total DNA present in the fecal specimens were extracted by chemical digestion with phenol-chloroform, according to previously described methods ( The negative control was performed in amplification reactions without the DNA template.
Detection of enterotoxigenic Bacteroides fragilis (ETBF) in the fecal specimens
The ETBF was directly detected in the fecal samples by PCR according to a previously established procedure (28) 
Antimicrobial drug susceptibility assays
The minimum inhibitory concentration (MIC) was determined by the agar dilution method, according to the NCCLS guidelines (23) The reference strain B. fragilis ATCC 25285 was included for quality control.
RESULTS
The fecal specimens were received and processed (n=90). Considering only the diarrheic feces, Bacteroides was detected in 55% (n=49), whereas Bacteroides was detected in 80.4% (n=41) of the non-diarrheic feces, as shown in Table 2 .
In this study Bacteroides sp. were considered for the cases in which amplicons suggestive of Bacteroides were observed, but there was no amplification of fragments expected in the specific reactions even after repetition of the experiments.
ETBF was detected in 4.6% of the fecal specimens evaluated, four being in diarrheic fecal specimens (3.7%) and four in nondiarrheic fecal specimens (6.15%). No positive correlation was observed between ETBF detection and donor gender.
Regarding the antimicrobial drug susceptibility patterns of the BFG isolates, the tests revealed bacterial resistance to all with the exception of metronidazole. The least efficient drugs were: ampicillin, ceftriaxone, clindamycin, chloramphenicol and meropenem. On the other hand, the most efficient drugs were the compounds ampicillin/sulbactam and piperacillin/tazobactam as summarized in Table 3 . Table 2 . Distribution of species within the Bacteroides fragilis group in diarrheic or non-diarrheic fecal samples from children aged 0-5 years old in Juiz de Fora, Brazil, detected directly by molecular biology, without microbiological culture. Enterotoxigenic strains were identified in 4.6% of the fecal samples. It is accepted that this number may vary from 6 to 12% of children in the USA, approximately 10% in Europe and around 2 to 15% in Asia (9, 11, 25, 29, 34, 35) . In Brazil, there is a lack of scientific data on the incidence of ETBF in the population; however, data show the incidence of these microorganisms in HIV-positive children (3.1%) (8) The use of chloramphenicol has been declining in many countries due to the toxicity of the drug, which causes intestinal disorders, depression and anemia. On the other hand, in our country, this drug is consumed widely and in our study a high rate of resistance was observed for this antimicrobial (7, 12, 26) . According to the literature, in the regions where the drug is still used for the treatment of infections in which BFG is involved, levels of resistance to chloramphenicol are up to 11%, though not all authors considered intermediary resistance (7, 20) .
In spite of the in vitro tests for the susceptibility of anaerobic bacteria that are not routinely considered for clinical decisions, some authors (2, 7, 13, 14, 35, 19) The results presented in this work on the distribution,
